XOMAP Q2 2025 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$13M+18.4% YoY

Gross Profit

$12M95.0% margin

Operating Income

$5M35.1% margin

Net Income

$9M70.0% margin

EPS (Diluted)

$0.52

QoQ Revenue Growth

-17.5%

Cash Flow

Operating Cash Flow

$6M

Free Cash Flow

$6M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$223M

Total Liabilities

$131M

Stockholders' Equity

$92M

Cash & Equivalents

$75M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13M	$11M	+18.4%
Gross Profit	$12M	$10M	+25.7%
Operating Income	$5M	-$10M	+145.7%
Net Income	$9M	$16M	-42.5%

Geographic Segments

UNITED STATES

$7M43%

SWITZERLAND

$6M34%

Asia Pacific

$4M23%